This week we're tracking new COVID-19 booster strategies targeting the XBB variant, Moderna's move into mRNA therapies for rare diseases, U. S. Food and Drug Administration guidelines to safeguard tattoo inks, challenges for European medical device startups, and a Scottish startup's pilot telerobot ... READ MORE >
5 things to know in life sciences: Week of June 5, 2023
This week we highlight a shortage of prescription medication in the United States. In addition, we discuss a Food and Drug Administration committee’s recommendation to approve a new RSV vaccine, comments on the Inflation Reduction Act impact, as well as a major acquisition in the diabetes space. Lastly, ... READ MORE >
5 things to know in life sciences: Week of May 29, 2023
This week, we explore the rise in Alzheimer's clinical trials despite recruitment hurdles, as well as the use of artificial intelligence in understanding gene interactions. In addition, we discuss SNIPR Biome's advances in CRISPR-based antibiotics and Tempus' launch of a data-access AI assistant for ... READ MORE >
5 things to know in life sciences: Week of May 22, 2023
This week we look at how artificial intelligence is revolutionizing voice banking for patients with conditions like amyotrophic lateral sclerosis, also known as ALS. In addition, we highlight proposed prescription drug transparency in Medicaid and how the Food and Drug Administration has changed its ... READ MORE >
5 things to know in life sciences: Week of May 15, 2023
This week we look at how changes to accelerated approvals at the U.S. Food and Drug Administration (FDA) are affecting the number of drugs being approved. Also this week, there is news of CVS’s brief foray into clinical trials, the end of the public health emergency for COVID-19, and the costs of the ... READ MORE >
5 things to know in life sciences: Week of May 8, 2023
This week we look at a paper published by the U.S. Food and Drug Administration related to artificial intelligence. We also highlight a statement from the World Health Organization declaring that mpox is no longer a global health emergency, a venture fund focused on blood-related research, and an effort ... READ MORE >
5 things to know in life sciences: Week of May 1, 2023
This week we look at how the world of digital health is facing an uncertain future when it comes to capital investment. We also examine how researchers have developed a "brain decoder" using neural network technology, gene therapy treatments that offer significant benefits but come with a steep cost, and ... READ MORE >
5 things to know in life sciences: Week of April 24, 2023
This week we look at a World Health Organization meeting on mRNA, using artificial intelligence to streamline clinical trials, Food and Drug Administration approval of a new blood cancer treatment and an upcoming Johnson & Johnson spinout. Finally, we highlight the resumption of a phase 2 trial on an ... READ MORE >
5 things to know in life sciences: Week of April 17, 2023
This week we look at a range of topics in the life sciences industry, from drug pricing negotiations and long-COVID-19 treatment to quantum computing in drug development. Each week we highlight five things affecting the life sciences industry. Here's the latest. Drug pricing negotiation policies are ... READ MORE >
5 things to know in life sciences: Week of April 10, 2023
This week we look at a range of topics in the life sciences industry, from the development of pediatric pacemakers to advancements in health care legislation. We also look at the over $1 billion in venture funds launched last week related to life sciences. Each week we highlight five things affecting ... READ MORE >